|
Male gender
|
379 (60.8)
|
|
Age, years
|
64.5 ± 16.2
|
|
Diabetic
|
287 (46.1)
|
|
Ethnicity, White
|
269 (43.2)
|
|
Ethnicity, Black
|
202 (32.4)
|
|
Ethnicity, Asian
|
149 (23.9)
|
|
Age, years
|
64.5 ± 16.2
|
|
Venous catheter, access
|
147 (23.6)
|
|
Arterio-venous fistula/graft access
|
445 (71.4)/31 (5.0)
|
|
Pre-dialysis weight, kg
|
71.5 (61.8–83.9)
|
|
Post-dialysis weight, kg
|
70.0 (60.7–82.1)
|
|
Ultrafiltration rate, mL/kg.h
|
6.0 (3.9–8.0)
|
|
Convection volume, L
|
19.1 (16.0–23.0)
|
|
Urea reduction ratio, %
|
74.6 (69.3–78.9)
|
|
Dialysis session time, h
|
4.0 (3.5–4.0)
|
|
Dialysate sodium, mmol/L
|
136 (136–138)
|
|
Dialysate potassium, mmol/L
|
2.0 (1.0–2.0)
|
|
Dialysate calcium, mmol/L
|
1.0 (1.0–1.25)
|
|
Dialysate temperature, °C
|
35.5 ± 0.7
|
|
Dialyzer surface area, m2
|
2.10 (1.8–2.2)
|
|
Tinzaparin, IU
|
2500 (2500–2500)
|
|
Serum sodium, mmol/L
|
139 ± 3.6
|
|
Serum urea, mmol/L
|
18.2 ± 5.8
|
|
Serum creatinine, umol/L
|
690 (547–861)
|
|
C-reactive protein, mg/L
|
6.0 (2.0–11.0)
|
|
Serum albumin, g/L
|
39 (36–41)
|
|
Haemoglobin, g/L
|
108.0 ± 14.3
|
|
Serum pro-brain natriuretic peptide, ng/L
|
5635 (1566–11,953)
|
|
Glycated haemoglobin, mmol/mol
|
47.5 (37.7–61.7)
|
|
Blood sugar, mmol/L
|
6.5 (5.4–8.2)
|
|
Prescribed antihypertensives
|
375 (60.2)
|
|
Myocardial infarction
|
115 (18.5)
|
|
Coronary artery bypass, surgery/stenting
|
43 (6.9)/58 (9.3)
|
|
Peripheral vascular disease
|
90 (16.4)
|
|
Renal artery stenosis/aortic aneurysm
|
24 (3.9)
|
|
Transient ischaemic attack
|
19 (3.1)
|
|
Cerebrovascular accident
|
65 (10.4)
|
|
Cancer
|
104 (16.7)
|
|
Frailty
|
4 (3–5)
|
|
Distress thermometer
|
3 (0–6)
|
|
Hand grip strength, kg
|
20.4 ± 10.5
|
